Glycemicon embraces partnerships to advance the discovery and development of novel, innovative products for people who cannot maintain their blood sugar levels in a healthy range. We are convinced that combining ideas and resources with our partners will bring products to markets with unmet needs faster and more efficiently.

Together we can make a difference.

Together we can help others!


Because of the lack of efficacious and safe products for the management of prediabetes, prediabetic people represent a highly interesting target group for THBA.

In addition to human use, THBA represents a very promising way to manage pre-diabetes in pets, in particular in cats.

For more information about partnering with Glycemicon please email